Loading
A phase 2 trial of Technetium Tc-99m sulfur colloid in Breast cancer, run by University of Southern California, recorded as terminated on the registry.
Sentinel and/or Axillary Lymph Node Biopsy With or Without Axillary Reverse Mapping in Reducing Incidence and Severity of Arm Lymphedema in Stage 0-2 Patients is a phase 2 interventional study registered as NCT01276054 by University of Southern California, with 4 participants recorded, started 2010-12 and due to reach its primary completion in 2011-10. Interventions recorded: technetium Tc 99m sulfur colloid, methylene blue, indocyanine green solution, sentinel lymph node biopsy, axillary lymph node biopsy, bioimpedance spectroscopy, quality-of-life assessment, lymphedema management. Conditions recorded: Lymphedema, Recurrent Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer.
Linked to the drug Technetium Tc-99m sulfur colloid because the registry names it among its interventions and Breast cancer among its conditions. Registry record only: no result has been read by an editor.
Shares Technetium Tc-99m sulfur colloid, Breast cancer (all types) and the tag pipeline.
Shares Technetium Tc-99m sulfur colloid and the tag pipeline.
Shares Breast cancer (all types) and the tag pipeline.
Shares Breast cancer (all types) and the tag pipeline.
Shares Breast cancer (all types) and the tag pipeline.
Shares Breast cancer (all types) and the tag pipeline.
Shares Breast cancer (all types) and the tag pipeline.
Shares Breast cancer (all types) and the tag pipeline.